Release Summary

The Hereditary Neuropathy Foundation (HNF) today announced a new partnership with Acetylon Pharmaceuticals, Inc., to explore potential therapies for Charcot-Marie-Tooth (CMT) Disease.

Hereditary Neuropathy Foundation